Last reviewed · How we verify

NCT04748900

Physiotherapy Treatment Plan in Allergic Bronchopulmonary Aspergillosis: Case Report

Completed Last updated 10 February 2021
What this trial tests

trial testing spirometer in Obstructive Pulmonary Disease in 1 participant. Completed in 5 February 2021.

Timeline
1 October 2020
Primary endpoint
3 February 2021
5 February 2021

Quick facts

Lead sponsorUniversidad Católica de Ávila
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1
Start date1 October 2020
Primary completion3 February 2021
Estimated completion5 February 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Católica de Ávila

Who can join

Adults 50 to 85, female only, with Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A spirometry study is performed in a patient diagnosed with allergic bronchopulmonary aspergillosis. An initial measurement is carried out and the patient is then put on a four-week physiotherapy treatment plan. Four spirometry measurements were taken to assess different variables and an improvement in all the spirometry values was established.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstructive Pulmonary Disease

Currently open trials in the same condition.

Other Universidad Católica de Ávila trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04748900.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing